by EmpathiCSubstanceS | Nov 8, 2020 | Psychedelic Medicine
A new study is presenting the first published data from preliminary human trials investigating the effect of psilocybin-assisted psychotherapy to treat major depressive disorder (MDD). The incredibly positive results have been described as just a “taste of things to...
by EmpathiCSubstanceS | Nov 8, 2020 | Psychedelic Medicine
MycoMeditations is a psychedelic-retreat company in Treasure Beach, Jamaica, that facilitates 10-day trips where attendees take psychedelic, or “magic,” mushrooms. Recent research has suggested that magic mushrooms, which contain the psychedelic compound...
by EmpathiCSubstanceS | Nov 8, 2020 | Psychedelic Medicine
There is a magical moment in the pharmaceutical industry when a government approves a new treatment. For companies researching psilocybin, the psychoactive component in psychedelic mushrooms, that moment is now. Late last year, the United States Food and Drug...
by EmpathiCSubstanceS | Nov 7, 2020 | Psychedelic Medicine
At 1 pm on Thursday, August 13, Zide Door—an entheogenic church in Oakland, California, that recognizes cannabis and psilocybin mushrooms as religious sacraments—was raided by Oakland Police Department (OPD) during parishioner visiting hours. Zide Door wasn’t just any...
by EmpathiCSubstanceS | Nov 7, 2020 | Psychedelic Medicine
August 4th, 2020 – Over 100 days after they first contacted the Health Minister of Canada–The Honourable Patty Hadju–four terminal cancer patients have been granted permission to use psilocybin therapy as a treatment for end-of-life stress and anxiety. After nearly...
